N/A N=44 Randomized Double-blind Diagnostic

FDG Uptake in Vaginal Tampons is Due to Urine

Cancer

Bottom Line

View on ClinicalTrials.gov: NCT01215318 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2019

Primary outcome: Primary: Number of FDG Positive Tampoons — 2; 10 FDG positive tampons

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: modified vaginal tampon (Device)
Age: Adult · 20+ yrs
Sex: Female
Sponsor: Irene Burger
Primary completion: Aug 2010

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of FDG Positive Tampoons	2; 10	—
SECONDARY Tampon Position Relative to the Pubococcygeal Line	5.9; 5.1	—

Summary

The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and can potentially impair image interpretation. The aim of this study is to determine the etiology of this artefact and identify potential means how to prevent it.

Eligibility Criteria

Inclusion criteria: premenopausal women with known or suspected malignancies who regularly used vaginal tampons during menstruation and thus were familiar with their use Exclusion criteria: No cervical or genital carcinoma. No vaginal infection.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01215318). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.